Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCARDIOVASCULAR

Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats

Yolanda Álvarez, José V. Pérez-Girón, Raquel Hernanz, Ana M. Briones, Ana García-Redondo, Amada Beltrán, María J. Alonso and Mercedes Salaices
Journal of Pharmacology and Experimental Therapeutics April 2007, 321 (1) 381-388; DOI: https://doi.org/10.1124/jpet.106.115287
Yolanda Álvarez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José V. Pérez-Girón
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Hernanz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana M. Briones
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana García-Redondo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amada Beltrán
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María J. Alonso
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mercedes Salaices
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 321 no. 1 381-388
DOI 
https://doi.org/10.1124/jpet.106.115287
PubMed 
17244722

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received October 10, 2006
  • Accepted January 19, 2007
  • Published online March 18, 2007.

Article Versions

  • Earlier version (January 23, 2007 - 11:01).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yolanda Álvarez,
  2. José V. Pérez-Girón,
  3. Raquel Hernanz,
  4. Ana M. Briones,
  5. Ana García-Redondo,
  6. Amada Beltrán,
  7. María J. Alonso and
  8. Mercedes Salaices
  1. Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain (Y.A., R.H., A.M.B., A.G.-R., A.B., M.J.A., M.S.); and Departamento de Ciencias de la Salud III, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain (J.V.P.-G., R.H., M.J.A.)
  1. Address correspondence to:
    Dr. Mercedes Salaices, Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid; 28029 Madrid, Spain. E-mail: mercedes.salaices{at}uam.es
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2007 to May 2022

AbstractFullPdf
Jan 2007120112
Feb 200780209
Mar 20074921141
Apr 2007204539
May 2007114341
Jun 2007102132
Jul 2007172845
Aug 2007111522
Sep 200792018
Oct 2007152120
Nov 200772421
Dec 20075107
Jan 2008111111
Feb 200819139
Mar 200881616
Apr 2008104937
May 200883833
Jun 200845028
Jul 2008132522
Aug 2008143423
Sep 2008194028
Oct 2008243019
Nov 2008255527
Dec 200813228
Jan 2009134416
Feb 2009144431
Mar 2009122615
Apr 2009151912
May 200962120
Jun 2009102820
Jul 2009212319
Aug 20097116
Sep 200972415
Oct 200914147
Nov 200912117
Dec 20091525
Jan 201012178
Feb 201017136
Mar 201011168
Apr 2010171310
May 2010203024
Jun 201093121
Jul 20108129
Aug 2010211110
Sep 2010102922
Oct 201091711
Nov 20108813
Dec 20103249
Jan 201142221
Feb 201182221
Mar 201118126
Apr 2011111616
May 2011112724
Jun 201171725
Jul 2011251119
Aug 2011202019
Sep 2011121512
Oct 201118148
Nov 201113178
Dec 2011398
Jan 2012141217
Feb 2012161816
Mar 2012211610
Apr 2012111722
May 2012101814
Jun 2012141412
Jul 201282313
Aug 2012122522
Sep 2012171615
Oct 2012281720
Nov 201225116
Dec 2012121819
Jan 201391313
Feb 201323919
Mar 2013201617
Apr 2013191517
May 201321117
Jun 20137196
Jul 2013111510
Aug 20136198
Sep 201312127
Oct 2013786
Nov 20139148
Dec 20138116
Jan 201413151
Feb 20144178
Mar 2014221212
Apr 2014182312
May 201420129
Jun 2014201911
Jul 2014102017
Aug 2014474
Sep 20146179
Oct 20148116
Nov 20141084
Dec 20141685
Jan 20151044
Feb 20158310
Mar 201592413
Apr 2015161218
May 2015894
Jun 201581513
Jul 2015121515
Aug 201513134
Sep 2015141210
Oct 20158119
Nov 20151166
Dec 2015775
Jan 201616108
Feb 2016557
Mar 2016231123
Apr 2016376
May 201681219
Jun 20165917
Jul 201681921
Aug 20166916
Sep 201691513
Oct 20161256
Nov 20161189
Dec 20162115
Jan 20170173
Feb 20171185
Mar 2017392
Apr 20170142
May 20175178
Jun 20170136
Jul 20170123
Aug 20171193
Sep 20173224
Oct 20172137
Nov 20173256
Dec 2017394
Jan 20183144
Feb 20184226
Mar 20181175
Apr 20180204
May 20185218
Jun 201822811
Jul 20180121
Aug 20180194
Sep 20180141
Oct 2018074
Nov 2018072
Dec 20181423
Jan 20191404
Feb 20191712
Mar 20191614
Apr 20193903
May 20191012
Jun 20198013
Jul 20191343
Aug 20191612
Sep 2019621
Oct 20191613
Nov 20192110
Dec 20191713
Jan 2020704
Feb 20203100
Mar 20201301
Apr 2020402
May 2020811
Jun 2020611
Jul 20201210
Aug 2020700
Sep 2020301
Oct 2020801
Nov 20201033
Dec 20201210
Jan 20212813
Feb 20211411
Mar 20212444
Apr 20211422
May 20211431
Jun 2021110
Jul 20211011
Aug 2021921
Sep 2021511
Oct 20211020
Nov 2021911
Dec 20211621
Jan 20221548
Feb 20221312
Mar 2022932
Apr 20222165
May 2022710

Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 381 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 381, Issue 2
1 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCARDIOVASCULAR

Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats

Yolanda Álvarez, José V. Pérez-Girón, Raquel Hernanz, Ana M. Briones, Ana García-Redondo, Amada Beltrán, María J. Alonso and Mercedes Salaices
Journal of Pharmacology and Experimental Therapeutics April 1, 2007, 321 (1) 381-388; DOI: https://doi.org/10.1124/jpet.106.115287

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCARDIOVASCULAR

Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats

Yolanda Álvarez, José V. Pérez-Girón, Raquel Hernanz, Ana M. Briones, Ana García-Redondo, Amada Beltrán, María J. Alonso and Mercedes Salaices
Journal of Pharmacology and Experimental Therapeutics April 1, 2007, 321 (1) 381-388; DOI: https://doi.org/10.1124/jpet.106.115287
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Optimized S-nitrosohemoglobin synthesis in red blood cells
  • High-Salt Diet Upregulates CaSR Expression and Signaling
  • L-Arginine improves post-infarction physical function
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics